NEW YORK (GenomeWeb) – Ambry Genetics on Wednesday announced it has acquired Progeny Software for an undisclosed amount.
Ambry said that it will integrate Progeny into its own laboratory information management system and use its software solutions and risk assessment tools to simplify client workflows. It added that the combined firms will facilitate research collaborations with clients of both firms and enable additional opportunities for population-based research and data sharing.
Michael Brammer will remain the CEO of Delray Beach, Fla.-based Progeny, which will operate as a subsidiary of Ambry. Among the products and services the company offers are pedigree and clinical data management, genotype data management, and sample management, according to its website. Progeny was founded in 1996 and has more than 1,900 customers in 78 countries.
Ambry said that Mark Pian, formerly of the University of California, San Diego School of Medicine and UCSD/Rady Children's Hospital Cystic Fibrosis Center, will head Progeny's advisory board.